SC
ROIV icon

Steven Cohen’s Roivant Sciences ROIV Stock Holding History

Steven Cohen’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$556K Sell
15,700
-21,000
-57% -$621K ﹤0.01% 3128
2026
Q1 		$1.02M Sell
36,700
-32,900
-47% -$845K ﹤0.01% 2753
2025
Q4 		$1.51M Buy
+69,600
New +$1.37M ﹤0.01% 2643

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Steven Cohen's ROIV Position: Q2 2026 in Review

Steven Cohen increased its Roivant Sciences (ROIV) stake by 402% in Q2 2026, buying an estimated $106M and bringing the position to 4,473,478 shares worth $158M. The position accounts for 0.17% of the portfolio, ranked #111.

Steven Cohen first reported a position in ROIV in Q2 2022 and has held it in 11 quarters since. 495 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Steven Cohen held 4,473,478 shares of Roivant Sciences worth $158M as of Q2 2026.
  • Steven Cohen bought 3,582,578 Roivant Sciences shares in Q2 2026, an estimated $106M.
  • Roivant Sciences made up 0.17% of Steven Cohen's portfolio in Q2 2026, its #111 holding.
  • Steven Cohen first reported a position in Roivant Sciences in Q2 2022 and has held it in 11 quarters since.
  • 495 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.